2020 Q1 Form 10-K Financial Statement

#000156459020007550 Filed on February 28, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 2018 Q4
Revenue $1.261M $9.291M
YoY Change -55.0% -19.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.937M
YoY Change -34.99%
Operating Profit $564.9K $5.469M
YoY Change -67.61% -3.51%
Interest Expense $3.966K $37.17K
YoY Change -24.46% -29.9%
% of Operating Profit 0.7% 0.68%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$52.80M -$7.294M
YoY Change 298.74% -88.76%
Net Earnings / Revenue -4186.36% -78.51%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 21.60M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $290.8M $500.0M
YoY Change -22.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $5.220M
YoY Change 1063.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $290.5M $494.8M
YoY Change
Total Liabilities & Shareholders Equity $500.0M
YoY Change -22.14%

Cashflow Statement

Concept 2020 Q1 2019 2018 Q4
OPERATING ACTIVITIES
Net Income -$52.80M -$7.294M
YoY Change 298.74% -88.76%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $4.291M $143.1M
YoY Change -85.58% 86.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $5.401M
YoY Change 0.04%
Common Stock Issuance & Retirement, Net $4.453M $134.3M
YoY Change -83.22% 75.13%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.453M -142.9M
YoY Change -85.03% 81.21%
NET CHANGE
Cash From Operating Activities 4.291M 143.1M
Cash From Investing Activities
Cash From Financing Activities -4.453M -142.9M
Net Change In Cash -161.9K 161.9K
YoY Change -107.16%
FREE CASH FLOW
Cash From Operating Activities $4.291M $143.1M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Assets
Assets
348039419
CY2017 us-gaap Dividend Income Operating
DividendIncomeOperating
837230
CY2017 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-5059883
CY2019Q4 us-gaap Cash
Cash
161884
CY2017Q4 us-gaap Cash
Cash
2260923
CY2019 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
337678
CY2018 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
11602950
CY2019 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
3562367
CY2018 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
5490679
CY2017 us-gaap Interest Expense
InterestExpense
6652
CY2019Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
21000000
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.56
CY2019Q4 dba Market Value Per Share
MarketValuePerShare
16.56
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-84619977
CY2019 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2019 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
115338
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2019Q4 us-gaap Dividends Receivable
DividendsReceivable
73985
CY2018Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
405215093
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
3480
CY2018Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
379135
CY2019Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
662
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
240542
CY2019Q4 us-gaap Liabilities
Liabilities
244022
CY2019Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
347794735
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
347795397
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348039419
CY2019Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2018Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
94741922
CY2019 us-gaap Dividend Income Operating
DividendIncomeOperating
2296630
CY2017 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
141040
CY2018 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
120748
CY2019 dba Management Fee Per Annum Of Daily Net Assets
ManagementFeePerAnnumOfDailyNetAssets
0.0085
CY2018 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2019Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
79123338
CY2019Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
120898494
CY2018Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
405215093
CY2018Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
79048368
CY2018Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
15693554
CY2018Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
499957015
CY2018Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
4491410
CY2019Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
147718751
CY2018Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
3263
CY2018Q4 us-gaap Liabilities
Liabilities
5219635
CY2018Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
678
CY2018Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
494780983
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
494781661
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
500001296
CY2018Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2018Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
29200000
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.94
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-42528693
CY2018 us-gaap Operating Expenses
OperatingExpenses
6056248
CY2017 us-gaap Operating Expenses
OperatingExpenses
6718563
CY2018 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
120748
CY2017 dba Operating Expenses Net
OperatingExpensesNet
6577523
CY2017 us-gaap Interest Income Operating
InterestIncomeOperating
5059883
CY2018 dba Operating Expenses Net
OperatingExpensesNet
5935500
CY2018 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-13515
CY2017 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
6129228
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-680410
CY2017 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-37799803
CY2017 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-5173
CY2017 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-37804976
CY2017 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
141040
CY2017 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
-78269
CY2018 us-gaap Interest Income Operating
InterestIncomeOperating
9734793
CY2017 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
582683
CY2018 us-gaap Interest Expense
InterestExpense
53019
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
5667450
CY2017 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-32156
CY2017 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-7650970
CY2017 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-7761395
CY2017 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
2241898985
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-46246781
CY2017 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
2049375350
CY2017 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1337361959
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-46246781
CY2017 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1231991521
CY2017 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-45566371
CY2017 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
557338
CY2017 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
23308
CY2017 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-71745
CY2017 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
989
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35310729
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
231714535
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
266945577
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35231042
CY2017 us-gaap Interest Paid Net
InterestPaidNet
6652
CY2017 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-110425
CY2019Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
147718751
CY2019Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
200021832
CY2019Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
62967
CY2019Q4 us-gaap Cash
Cash
161884
CY2018Q4 us-gaap Dividends Receivable
DividendsReceivable
44281
CY2018Q4 us-gaap Assets
Assets
500001296
CY2018Q4 dba Payable To Clearing Organizations
PayableToClearingOrganizations
1623523
CY2018Q4 dba Payable Due To Custodian
PayableDueToCustodian
3213714
CY2019Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
347580306
CY2019Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.9998
CY2019Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
347740583
CY2018Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
499901020
CY2018Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0105
CY2018Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
499957015
CY2019 us-gaap Interest Income Operating
InterestIncomeOperating
6993884
CY2017 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5897113
CY2019 us-gaap Interest Expense
InterestExpense
37166
CY2019 dba Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
11336
CY2019 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
115338
CY2019 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
35880
CY2018Q4 dba Market Value Per Share
MarketValuePerShare
16.95
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
5468641
CY2018 us-gaap Dividend Income Operating
DividendIncomeOperating
1868157
CY2019 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9290514
CY2019 us-gaap Operating Expenses
OperatingExpenses
3937211
CY2019 dba Operating Expenses Net
OperatingExpensesNet
3821873
CY2018 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
512550
CY2018 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
13890253
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14073703
CY2018 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-70559789
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
29718607
CY2019 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
74970
CY2018 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
127449
CY2019 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
29614325
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-42481477
CY2018 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-84633492
CY2018 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
56001
CY2019 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-12762870
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
89315901
CY2019 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
223607356
CY2019 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-134291455
CY2019 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5400580
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
5468641
CY2019 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-42481477
CY2019 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
29718607
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7294229
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
347795397
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
187262346
CY2018 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
263941886
CY2018 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-76679540
CY2018 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5398207
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
5667450
CY2018 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-84633492
CY2018 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
14073703
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-64892339
CY2018 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-146970086
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
494781661
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-680410
CY2017 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-37804976
CY2017 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-7761395
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-46246781
CY2017 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-81477823
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
641751747
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-64892339
CY2019 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
938196266
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
641751747
CY2019 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1138675218
CY2018 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
749503577
CY2019 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1033470278
CY2018 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
779637410
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-6974031
CY2018 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-9695040
CY2019 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
35880
CY2018 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-13515
CY2017 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-5173
CY2018 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1343705445
CY2019 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1202731831
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
494781661
CY2019 dba Increase Decrease In Payable For Amount Due To Custodian
IncreaseDecreaseInPayableForAmountDueToCustodian
-3213714
CY2018 dba Increase Decrease In Payable For Amount Due To Custodian
IncreaseDecreaseInPayableForAmountDueToCustodian
3213714
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142905749
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-78864033
CY2019 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
161884
CY2018 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-2260923
CY2017 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
79687
CY2017Q4 us-gaap Cash
Cash
2260923
CY2016Q4 us-gaap Cash
Cash
2181236
CY2019 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
104282
CY2018 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
183450
CY2019 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
1686490
CY2018 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-2066075
CY2019 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
29704
CY2018 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
10669
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-138593
CY2018 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-65280
CY2019 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
217
CY2018 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-828
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143067633
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76603110
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
5400580
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
5398207
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
89315901
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
187262346
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
223607356
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
263941886
CY2019 us-gaap Interest Paid Net
InterestPaidNet
37166
CY2018 us-gaap Interest Paid Net
InterestPaidNet
53019
CY2006Q3 dba Number Of Series Of Trusts
NumberOfSeriesOfTrusts
7
CY2019 us-gaap Business Acquisition Date Of Acquisition Agreement1
BusinessAcquisitionDateOfAcquisitionAgreement1
2015-02-23
CY2015Q1 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2019 dba Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
CY2019 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2019 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
200000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">B.</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Accounting Estimates</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</p>
CY2019 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2019-12-31
CY2019 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2019-12-24
CY2019 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5 - Deposits with Commodity Broker and Custodian</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund defines cash as cash held by the Custodian. There were no cash equivalents held by the Fund as of December 31, 2019 and 2018.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the commodity futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements. </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption <span style="font-style:italic;">Due to custodian</span>.</p>
CY2018Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
22352295
CY2018Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-17860885
CY2018Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
482096130
CY2019 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2019 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
200000
CY2019 dba Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2019 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
200000
CY2019Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
13955785
CY2019Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
2202345
CY2019Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
11753440
CY2019Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
359494023
CY2019Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
347740583
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.94
CY2017Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.76
CY2016Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
19.98
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.33
CY2018 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.80
CY2017 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.20
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.21
CY2018 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.16
CY2017 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.02
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.12
CY2018 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.64
CY2017 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.22
CY2019 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.26
CY2018 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.18
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.56
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.94
CY2017Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.76
CY2018Q4 dba Market Value Per Share
MarketValuePerShare
16.95
CY2017Q4 dba Market Value Per Share
MarketValuePerShare
18.75
CY2016Q4 dba Market Value Per Share
MarketValuePerShare
19.98
CY2019Q4 dba Market Value Per Share
MarketValuePerShare
16.56
CY2018Q4 dba Market Value Per Share
MarketValuePerShare
16.95
CY2017Q4 dba Market Value Per Share
MarketValuePerShare
18.75
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0130
CY2018 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0088
CY2017 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0009
CY2019 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0091
CY2018 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0092
CY2017 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0091
CY2019 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0094
CY2018 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0094
CY2017 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0093
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0070
CY2018 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0874
CY2017 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0611
CY2019 dba Return At Market Value
ReturnAtMarketValue
-0.0076
CY2018 dba Return At Market Value
ReturnAtMarketValue
-0.0864
CY2017 dba Return At Market Value
ReturnAtMarketValue
-0.0616
CY2018 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
1224468152

Files In Submission

Name View Source Status
0001564590-20-007550-index-headers.html Edgar Link pending
0001564590-20-007550-index.html Edgar Link pending
0001564590-20-007550.txt Edgar Link pending
0001564590-20-007550-xbrl.zip Edgar Link pending
dba-10k_20191231.htm Edgar Link pending
dba-10k_20191231_htm.xml Edgar Link completed
dba-20191231.xsd Edgar Link pending
dba-20191231_cal.xml Edgar Link unprocessable
dba-20191231_def.xml Edgar Link unprocessable
dba-20191231_lab.xml Edgar Link unprocessable
dba-20191231_pre.xml Edgar Link unprocessable
dba-ex231_325.htm Edgar Link pending
dba-ex311_8.htm Edgar Link pending
dba-ex312_7.htm Edgar Link pending
dba-ex321_9.htm Edgar Link pending
dba-ex322_6.htm Edgar Link pending
dba-ex43_158.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gojq1biicipw000001.jpg Edgar Link pending
gojq1biicipw000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending